TrialJournal of gynecologic oncology2021

A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial.

Kensuke Hori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.